At close: December 24 at 2:00:27 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 17 | 17 |
| Avg. Estimate | 0 | 0 | 4.52 | 7.23 |
| Low Estimate | 0 | 0 | 4.06 | 5.55 |
| High Estimate | 0 | 0 | 5.16 | 8.5 |
| Year Ago EPS | -- | -- | 4.2 | 4.52 |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 16 | 16 |
| Avg. Estimate | -- | -- | 5.82B | 6.79B |
| Low Estimate | -- | -- | 5.47B | 6.37B |
| High Estimate | -- | -- | 6.15B | 7.62B |
| Year Ago Sales | -- | -- | 5.25B | 5.82B |
| Sales Growth (year/est) | -- | -- | 10.76% | 16.66% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 4.36 | 7.15 |
| 7 Days Ago | 0 | 0 | 4.52 | 7.23 |
| 30 Days Ago | 0 | 0 | 4.52 | 7.23 |
| 60 Days Ago | 0 | 0 | 4.45 | 7.04 |
| 90 Days Ago | 0 | 0 | 4.41 | 7.17 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | -- | -- | 4 | 5 |
| Down Last 7 Days | -- | -- | 2 | 1 |
| Down Last 30 Days | -- | -- | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UCB.BR | -- | -- | 7.69% | 59.78% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Related Tickers
TUB.BR Financière de Tubize SA
141.00
-0.56%
ARGX.BR argenx SE
604.60
+1.55%
ARGX argenx SE
634.70
+0.75%
ONWD.BR Onward Medical N.V.
5.34
-1.84%
AGIO Agios Pharmaceuticals, Inc.
34.15
-0.12%
BIOS.BR BioSenic S.A.
0.0057
-6.56%
MRUS Merus N.V.
42.75
+0.80%
MLTX MoonLake Immunotherapeutics
54.74
+3.93%
CRGX CARGO Therapeutics, Inc.
14.71
+0.34%
GLPG Galapagos NV
27.36
+0.55%